[Preliminary results of the use of an antimycotic drug, clotrimazole (bis-phenyl-(2-chlorophenyl)-1-imidazoly-methane: BAY b 5097) in local administration for therapy of vaginitis caused by Candida albicans and by Trichomonas vaginalis].
D000935:Antifungal Agents / Q000627:therapeutic use*; D000994:Antitrichomonal Agents / Q000627:therapeutic use*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D003022:Clotrimazole / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D014247:Trichomonas Vaginitis / Q000188:drug therapy*
D000935:Antifungal Agents; D000994:Antitrichomonal Agents; D007093:Imidazoles; D003022:Clotrimazole
Primi risultati dell'impiego di un antimicotico, clotrimazolo (bis-fenil-(2-clorofenil)-1-imidazolil-metano: BAY b 5097) ad uso locale nella terapia delle vaginiti da Candida albicans e da Trichomonas vaginalis